Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00038623
Status:
COMPLETED
Last Update Posted:
2011-11-02
First Post:
2002-06-03
Brief Title:
Study Of Yttrium-ibritumomab Zevalin For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-04
Start Date Type:
None
Primary Completion Date:
2007-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-02
Completion Date Type:
ACTUAL
First Submit Date:
2002-06-03
First Submit QC Date:
June 3 2002
Study First Post Date:
2002-06-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-10-31
Last Update Post Date:
2011-11-02
Last Update Post Date Type:
ESTIMATED